Related Experiment Video
Updated: Jul 11, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Exploring the Influence of Health Insurance Plans on Biosimilar Adoption Rates
Jeremy Costin1, Morgane C Mouslim2, Mariana P Socal3
1Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Background:
We conducted a study to investigate the role of health insurance plans on biosimilar adoption among commercially insured patients in the USA. Flexible and rigid health plans may exhibit differing biosimilar coverage due to variations in cost considerations, formulary design, and provider networks.
Objective:
To identify the characteristics of switchers and biosimilar initiators for six biologic-biosimilar pairs.
Methods:
Using claims data from 2015 to 2019, we implement sequential regression models to assess the role of health plans on biosimilars adoption.
Findings:
We found that low-flexibility plans, such as Health Maintenance Organization (HMOs) and Exclusive Provider Organization (EPOs), are more likely to have patients who are switchers and/or biosimilar initiators.
Conclusion:
Our findings highlight the importance of health insurance plan design in promoting biosimilar uptake.
More Related Videos
06:26Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Bioequivalence: Overview
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioavailability: Overview
Factors Influencing Bioavailability: First-Pass Elimination
Biopharmaceutics and Pharmacokinetics: Overview